The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer
| Autor: | Delgado, J., Vleminckx, C., Sarac, S., Sosa, A., Bergh, J., Giuliani, R., Enzmann, H., Pignatti, F. |
|---|---|
| Zdroj: | In ESMO Open April 2021 6(2) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|